These are indeed Enterochromaffin cells. However, I'd suggest a small simplification of the annotation: Instead of EEC Enterochromaffin Cells, either Enterochromaffin Cells or its abbreviation (ECC) would suffice.
These are indeed Enterochromaffin cells. However, I'd suggest a small simplification of the annotation: Instead of EEC Enterochromaffin Cells, either Enterochromaffin Cells or its abbreviation (ECC) would suffice.
These are indeed enteroendocrine cells (EEC). However, they do not express high levels of peptide hormones and could represent an intermediate state. They lack early EEC transcription factors (i.e. DLL1, NEUROG3), and seem to be somewhat enriched for transcription factors linked to EEC intermediate/late states (e.g. RFX3, RFX2, ETV1). They seem to express low levels of NTS, GCG and PYY, but are overall negative other enteroendocrine hormones. For reference: PMID: 30712869.
For a matter of consistency, if there is interest to differentiate immature Goblet Cells from fully mature Goblet Cells, this cluster could be split. Cluster 6 contains Mature Goblet Cells expressing the marker TFF1. Cluster 11 lacks this marker.
These are indeed bona fide Paneth Cells, as they express the canonical markers DEFA5, DEFA6. However, as mentioned by others, "Secretory" is a redundant term and should be removed.
The “Secretory TA” annotation is not broadly adopted in the literature, but these cells are clearly engaged with the secretory lineage (e.g., HES6, TFF3, etc), while also expressing canonical proliferation markers (MKI67, TOP2A, PCNA) typical of transit-amplifying cells.
Although non-standard, this annotation could be arbitrarily employed here to capture their dual proliferative and secretory commitment.
A minor annotation simplification could be applied: replacing “EEC S Cells (SCT+)” by “S-type EEC" or even "S-EEC". The "C" already stands for cells.
A minor annotation simplification could be applied: replacing “EEC L Cells (PYY+)” with “L-type EEC" or even "L-EEC". The "C" already stands for cells.
A minor annotation simplification could be applied: replacing “EEC N Cells” with “N-type EEC" or even "N-EEC". The "C" already stands for cells.
These cells express some colonocyte markers such as CA2 and CA1, but still lacks AQP8 (colonocyte late marker). In my opinion, these cells are in a state between Colonocytes Early and Late. Therefore, for consistency, they could be annotated as Colonocytes Intermediate.
As also noted by Tatiana, these two clusters should be merged. By definition, all TA cells should display markers of proliferation (e.g. MKI67, TOP2A, PCNA).
As also noted by Tatiana, these two clusters should be merged. By definition, all TA cells should display markers of proliferation (e.g. MKI67, TOP2A, PCNA).
While the “Absorptive TA” designation is conceptually appealing, the size of this population is likely overestimated in the current annotation.
Transit-amplifying (TA) cells, defined by high proliferative signatures (e.g., MKI67, PCNA, TOP2A) are largely confined to clusters 9 and 13 at Leiden_Lineage_L1 resolution, with some contributions from clusters 0 and 1.
At Leiden_Lineage_L2 resolution, the following subclusters align with TA/Absorptive TA identity:
Subcluster 1_0: REG1A, OLFM4, DUT, PCNA (proliferative progenitor signature).
Subcluster 1_3: REG1A, OLFM4, MKI67 (proliferative progenitor signature).
Subcluster 0_2 (colorectum): LEFTY1, DUT, TUBB, PCNA.
Subclusters that should not be annotated as TA/Absorptive TA
Subcluster 1_2: Expresses progenitor markers (OLFM4, ADH1C) and early absorptive markers (GSTA1), but lacks canonical proliferation markers (MKI67, PCNA, TOP2A). Since TA cells are highly proliferative by definition, and 1_2 seems to precede Enterocyte Early, this subcluster (along with 1_5 (REG1A, OLFM4, LCN2)) could be annotated as Enterocyte Progenitors (noting that "progenitor" is less strict than TA, as it does not require the same high level of proliferation).
Subcluster 0_0: these cells are halfway-differentiated colonocytes (CA1, CA2). My suggestion would be to merge them with with the Colonocyte cluster and annotate as Colonocyte Intermediate (per prior feedback).
The current annotation of this cluster is appropriate and well supported by its marker gene signature. GP2 is a canonical marker of this population and has most recently been proposed as a marker of terminally differentiated M cells. In the same study, ICAM2 was reported as an additional and more general M cell marker (Spoelstra et al., Nature, 2026; PMID: 41372409).
The current annotation of this cluster is appropriate and supported by the marker gene signature (PMID: 32407674).
These immune cells should be removed from here.
These immune cells should be removed from here.
These cells are a subset of Colonocytes Late, since they are enriched for AQP8 (PMID: 35176508). I'd re-annotate them as LAMA3+ Colonocytes, if you'd like to highlight enrichment for this laminin subunit. Alternatively, they could be merged with Colonocytes Late.
This annotation requires review. Follicle-associated epithelial (FAE) cells is a term often used interchangeably with microfold (M) cells, which this cluster does not represent. Instead, these cells mark an early stage of BEST4+ colonocytes, as evidenced by highly variable genes including BEST4, OTOP2, SPIB, LYZ, HES4, CA7, and NOTCH2. Stem/pluripotency-associated markers LEFTY1 and OLFM4 suggest an early differentiation stage. For consistency with other annotations, I’d recommend these cells are annotated as "BEST4+ Colonocytes Early". This subset aligns with descriptions in (PMID: 30814735, PMID: 30814735, PMID: 35176508).
As mentioned by others, the term secretory here is redundant. The annotation could be simplified to "Tuft Cells".
Small suggestion; instead of Colonocytes BEST4, the most used annotation is "BEST4+ Colonocytes".
Small suggestion; instead of Enterocytes BEST4, the most used annotation is "BEST4+ Enterocytes".
These are indeed intestinal stem cells (i.e. enrichment for LGR5, SMOC2 and ASCL2). However, as recommended by others, the annotation should be refined to Intestinal Stem Cells instead of Epithelial Stem Cells (LGR5+).
The annotation "Enterocytes Early" seems appropriate. We have a similar population enriched for GSTA1 and GSTA2 in our duodenal dataset and we attributed a similar annotation to them.
These are indeed Enterochromaffin cells. However, I'd suggest a small simplification of the annotation: Instead of EEC Enterochromaffin Cells, either Enterochromaffin Cells or its abbreviation (ECC) would suffice.
These are indeed enteroendocrine cells (EEC). However, they do not express high levels of peptide hormones and could represent an intermediate state. They lack early EEC transcription factors (i.e. DLL1, NEUROG3), and seem to be somewhat enriched for transcription factors linked to EEC intermediate/late states (e.g. RFX3, RFX2, ETV1). They seem to express low levels of NTS, GCG and PYY, but are overall negative other enteroendocrine hormones. For reference: PMID: 30712869.
For a matter of consistency, if there is interest to differentiate immature Goblet Cells from fully mature Goblet Cells, this cluster could be split. Cluster 6 contains Mature Goblet Cells expressing the marker TFF1. Cluster 11 lacks this marker.
These are indeed bona fide Paneth Cells, as they express the canonical markers DEFA5, DEFA6. However, as mentioned by others, "Secretory" is a redundant term and should be removed.
The “Secretory TA” annotation is not broadly adopted in the literature, but these cells are clearly engaged with the secretory lineage (e.g., HES6, TFF3, etc), while also expressing canonical proliferation markers (MKI67, TOP2A, PCNA) typical of transit-amplifying cells.
Although non-standard, this annotation could be arbitrarily employed here to capture their dual proliferative and secretory commitment.
A minor annotation simplification could be applied: replacing “EEC S Cells (SCT+)” by “S-type EEC" or even "S-EEC". The "C" already stands for cells.
A minor annotation simplification could be applied: replacing “EEC L Cells (PYY+)” with “L-type EEC" or even "L-EEC". The "C" already stands for cells.
A minor annotation simplification could be applied: replacing “EEC N Cells” with “N-type EEC" or even "N-EEC". The "C" already stands for cells.
These cells express some colonocyte markers such as CA2 and CA1, but still lacks AQP8 (colonocyte late marker). In my opinion, these cells are in a state between Colonocytes Early and Late. Therefore, for consistency, they could be annotated as Colonocytes Intermediate.
As also noted by Tatiana, these two clusters should be merged. By definition, all TA cells should display markers of proliferation (e.g. MKI67, TOP2A, PCNA).
As also noted by Tatiana, these two clusters should be merged. By definition, all TA cells should display markers of proliferation (e.g. MKI67, TOP2A, PCNA).
While the “Absorptive TA” designation is conceptually appealing, the size of this population is likely overestimated in the current annotation.
Transit-amplifying (TA) cells, defined by high proliferative signatures (e.g., MKI67, PCNA, TOP2A) are largely confined to clusters 9 and 13 at Leiden_Lineage_L1 resolution, with some contributions from clusters 0 and 1.
At Leiden_Lineage_L2 resolution, the following subclusters align with TA/Absorptive TA identity:
Subcluster 1_0: REG1A, OLFM4, DUT, PCNA (proliferative progenitor signature).
Subcluster 1_3: REG1A, OLFM4, MKI67 (proliferative progenitor signature).
Subcluster 0_2 (colorectum): LEFTY1, DUT, TUBB, PCNA.
Subclusters that should not be annotated as TA/Absorptive TA
Subcluster 1_2: Expresses progenitor markers (OLFM4, ADH1C) and early absorptive markers (GSTA1), but lacks canonical proliferation markers (MKI67, PCNA, TOP2A). Since TA cells are highly proliferative by definition, and 1_2 seems to precede Enterocyte Early, this subcluster (along with 1_5 (REG1A, OLFM4, LCN2)) could be annotated as Enterocyte Progenitors (noting that "progenitor" is less strict than TA, as it does not require the same high level of proliferation).
Subcluster 0_0: these cells are halfway-differentiated colonocytes (CA1, CA2). My suggestion would be to merge them with with the Colonocyte cluster and annotate as Colonocyte Intermediate (per prior feedback).
The current annotation of this cluster is appropriate and well supported by its marker gene signature. GP2 is a canonical marker of this population and has most recently been proposed as a marker of terminally differentiated M cells. In the same study, ICAM2 was reported as an additional and more general M cell marker (Spoelstra et al., Nature, 2026; PMID: 41372409).
The current annotation of this cluster is appropriate and supported by the marker gene signature (PMID: 32407674).
These immune cells should be removed from here.
These immune cells should be removed from here.
These cells are a subset of Colonocytes Late, since they are enriched for AQP8 (PMID: 35176508). I'd re-annotate them as LAMA3+ Colonocytes, if you'd like to highlight enrichment for this laminin subunit. Alternatively, they could be merged with Colonocytes Late.
This annotation requires review. Follicle-associated epithelial (FAE) cells is a term often used interchangeably with microfold (M) cells, which this cluster does not represent. Instead, these cells mark an early stage of BEST4+ colonocytes, as evidenced by highly variable genes including BEST4, OTOP2, SPIB, LYZ, HES4, CA7, and NOTCH2. Stem/pluripotency-associated markers LEFTY1 and OLFM4 suggest an early differentiation stage. For consistency with other annotations, I’d recommend these cells are annotated as "BEST4+ Colonocytes Early". This subset aligns with descriptions in (PMID: 30814735, PMID: 30814735, PMID: 35176508).
As mentioned by others, the term secretory here is redundant. The annotation could be simplified to "Tuft Cells".
Small suggestion; instead of Colonocytes BEST4, the most used annotation is "BEST4+ Colonocytes".
Small suggestion; instead of Enterocytes BEST4, the most used annotation is "BEST4+ Enterocytes".
These are indeed intestinal stem cells (i.e. enrichment for LGR5, SMOC2 and ASCL2). However, as recommended by others, the annotation should be refined to Intestinal Stem Cells instead of Epithelial Stem Cells (LGR5+).
The annotation "Enterocytes Early" seems appropriate. We have a similar population enriched for GSTA1 and GSTA2 in our duodenal dataset and we attributed a similar annotation to them.